Search Results
Found 1 results
510(k) Data Aggregation
(185 days)
FASTPACK TOTAL PSA METHOD VERIFICATION KIT
The FastPack® Total PSA Method Verification Kit consists of assayed quality control materials for verification of the calibration and reportable range of the FastPack® Total PSA Immunoassay to meet CLIA requirements.
The FastPack® PSA Method Verification Kit The FastPack® Total PSA Method Verification kit components are in liquid form, in vials, from which the user can directly remove sample. They are formulated at three (3) levels packaged together as a kit.
The provided text is a 510(k) summary for the FastPack® Total PSA Method Verification Kit. It describes the device, its intended use, and compares it to a predicate device. However, this document does not contain information about specific acceptance criteria or a study proving the device meets those criteria, as typically found in performance studies for diagnostic devices.
The document focuses on demonstrating substantial equivalence to a predicate device based on similar features and intended use. The "Method Verification Kit" itself is a quality control material used to verify the calibration and reportable range of another immunoassay (the FastPack® Total PSA Immunoassay), rather than a device that directly measures a patient's analyte. Therefore, the "performance" of this kit is assessed by its characteristics as a quality control material (e.g., PSA concentrations, matrix, form), not by diagnostic accuracy metrics.
Here's a breakdown of the requested information based on the provided text, with explicit statements where information is not present:
1. Table of Acceptance Criteria and Reported Device Performance
No explicit acceptance criteria or a numerical performance table for the "FastPack® Total PSA Method Verification Kit" are provided in this document. The document states it is a "Method Verification Kit" and compares its features to a "Predicate Device" in a table. This comparison highlights attributes like intended use, analytes, matrix, form, volume, and levels of PSA concentrations. It does not present performance metrics against predefined acceptance criteria.
Acceptance Criteria | Reported Device Performance |
---|---|
Not specified for the Method Verification Kit's performance. | Not specified in terms of performance metrics. |
Comparison to Predicate Device (Features): | |
Intended Use | New Device: Assayed quality control materials for the verification of the calibration and reportable range of the FastPack® Total PSA Immunoassay to meet CLIA requirements. |
Analytes | Total PSA |
Matrix | Bovine Serum Albumin |
Form | Liquid |
Volume | 5.0 mL |
Levels | 3 levels (0 ng/mL, 25 ng/mL, 50 ng/mL) |
2. Sample size used for the test set and the data provenance
- Sample size from the test set: Not applicable/Not provided. The kit itself is a quality control material, not a diagnostic test performed on patient samples.
- Data provenance: Not applicable/Not provided.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- Number of experts: Not applicable/Not provided. This device is a quality control material, not a diagnostic device requiring expert interpretation of results.
- Qualifications of experts: Not applicable/Not provided.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Adjudication method: Not applicable/None. This device is a quality control material.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- MRMC study: No. This device is a quality control material and not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Standalone performance study: No. This device is a quality control material.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
- Type of ground truth: Not applicable/Not provided in the context of diagnostic accuracy. For the quality control material itself, the specified PSA concentrations (0 ng/mL, 25 ng/mL, 50 ng/mL) would serve as the "true" values for verifying the immunoassay. How these concentrations were established (e.g., gravimetric preparation against a standard) is not detailed in this document.
8. The sample size for the training set
- Training set sample size: Not applicable/Not provided. This document describes a quality control material, not a machine learning model.
9. How the ground truth for the training set was established
- Ground truth for training set: Not applicable/Not provided.
Ask a specific question about this device
Page 1 of 1